James Wallace

James Wallace is a seasoned executive with extensive experience in strategic leadership and business development across the healthcare, aerospace, and insurance industries. Currently serving as the Chief Executive Officer of DecisionRx, Inc., James integrates medication therapy management and pharmacogenomics to enhance clinical outcomes. With a strong academic background including a Doctor of Business Administration from the University of South Florida and an MBA from Harvard Business School, James has held significant roles such as CEO of Future Health ESG Corp and President of AmeriPlus Select Services, while also offering strategic advisory services to various organizations. As a Senior Researcher at Harvard Business School and director of The GENiE Group, James contributes to innovation research in healthcare.